KDM5 lysine demethylases are involved in maintenance of 3′UTR length

Science Advances

Volumn 2, Issue 11, 2016, Pages

  Blair, Lauren P ^a,f   Liu, Zongzhi ^a   Labitigan, Ramon Lorenzo D ^a,g   Wu, Lizhen ^a   Zheng, Dinghai ^b   Xia, Zheng ^c,h   Pearson, Erica L ^d   Nazeer, Fathima I ^d,i   Cao, Jian ^a   Lang, Sabine M ^a   Rines, Rachel J ^a,j   Mackintosh, Samuel G ^e   Moore, Claire L ^d   Li, Wei ^c   Tian, Bin ^b   Tackett, Alan J ^e   Yan, Qin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f ASTRAZENECA   (United Kingdom)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ STATE UNIVERSITY OF NEW YORK AT POTSDAM   (United States)

^j PFIZER INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; GENES; MACHINERY; MAMMALS; NUCLEIC ACIDS; TRANSCRIPTION; YEAST;

BREAST CANCER CELLS; COUPLED MECHANISMS; HUMAN BREAST; MAMMALIAN HOMOLOGS; POLYADENYLATION; PROCESSING MACHINERY; PROTEIN EXPRESSIONS; UNTRANSLATED REGIONS;

GENE EXPRESSION;

CCND1 PROTEIN, HUMAN; CYCLIN D1; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; HISTONE DEMETHYLASE; JHD2 PROTEIN, S CEREVISIAE; KDM5A PROTEIN, HUMAN; KDM5B PROTEIN, HUMAN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; RETINOBLASTOMA BINDING PROTEIN 2; RIBONUCLEASE III; SACCHAROMYCES CEREVISIAE PROTEIN; TUMOR PROTEIN;

3' UNTRANSLATED REGION; BREAST TUMOR; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; MCF-7 CELL LINE; METABOLISM; SACCHAROMYCES CEREVISIAE;

3' UNTRANSLATED REGIONS; BREAST NEOPLASMS; CYCLIN D1; DEAD-BOX RNA HELICASES; FEMALE; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MCF-7 CELLS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; REPRESSOR PROTEINS; RETINOBLASTOMA-BINDING PROTEIN 2; RIBONUCLEASE III; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 85026398015     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1501662     Document Type: Article

References (76)

1. E. L. Greer, Y. Shi, Histone methylation: A dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13, 343-357 (2012).
2. G. Liang, R. J. Klose, K. E. Gardner, Y. Zhang, Yeast Jhd2p is a histone H3 Lys4 trimethyl demethylase. Nat. Struct. Mol. Biol. 14, 243-245 (2007).
3. D. J. Seward, G. Cubberley, S. Kim, M. Schonewald, L. Zhang, B. Tripet, D. L. Bentley, Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins. Nat. Struct. Mol. Biol. 14, 240-242 (2007).
4. S. Tu, E. M. M. Bulloch, L. Yang, C. Ren, W.-C. Huang, P.-H. Hsu, C.-H. Chen, C.-L. Liao, H.-M. Yu, W.-S. Lo, M. A. Freitas, M.-D. Tsai, Identification of histone demethylases in Saccharomyces cerevisiae. J. Biol. Chem. 282, 14262-14271 (2007).
5. D. P. Mersman, H.-N. Du, I. M. Fingerman, P. F. South, S. D. Briggs, Polyubiquitination of the demethylase Jhd2 controls histone methylation and gene expression. Genes Dev. 23, 951-962 (2009).
6. J. Mata, Genome-wide mapping of polyadenylation sites in fission yeast reveals widespread alternative polyadenylation. RNA Biol. 10, 1407-1414 (2013).
7. Y. Lin, Z. Li, F. Ozsolak, S. Woo Kim, G. Arango-Argoty, T. T. Liu, S. A. Tenenbaum, T. Bailey, A. Paula Monaghan, P. M. Milos, B. John, An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res. 40, 8460-8471 (2012).
8. Y. Shi, Alternative polyadenylation: New insights from global analyses. RNA 18, 2105-2117 (2012).
9. L. Wang, R. D. Dowell, R. Yi, Genome-wide maps of polyadenylation reveal dynamic mRNA 3′-end formation in mammalian cell lineages. RNA 19, 413-425 (2013).
10. S. C. Boutet, T. H. Cheung, N. L. Quach, L. Liu, S. L. Prescott, A. Edalati, K. Iori, T. A. Rando, Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. Cell Stem Cell 10, 327-336 (2012).
11. R. Elkon, A. P. Ugalde, R. Agami, Alternative cleavage and polyadenylation: Extent, regulation and function. Nat. Rev. Genet. 14, 496-506 (2013).
12. B. Tian, J. L. Manley, Alternative cleavage and polyadenylation: The long and short of it. Trends Biochem. Sci. 38, 312-320 (2013).
13. S. Millevoi, S. Vagner, Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation. Nucleic Acids Res. 38, 2757-2774 (2010).
14. H. P. Phatnani, A. L. Greenleaf, Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 20, 2922-2936 (2006).
15. S. A. Johnson, G. Cubberley, D. L. Bentley, Cotranscriptional recruitment of the mRNA export factor Yra1 by direct interaction with the 3′ end processing factor Pcf11. Mol. Cell 33, 215-226 (2009).
16. S. A. Johnson, H. Kim, B. Erickson, D. L. Bentley, The export factor Yra1 modulates mRNA 3′ end processing. Nat. Struct. Mol. Biol. 18, 1164-1471 (2011).
17. F. Huang, M. B. Chandrasekharan, Y.-C. Chen, S. Bhaskara, S. W. Hiebert, Z.-W. Sun, The JmjN domain of Jhd2 is important for its protein stability, and the plant homeodomain (PHD) finger mediates its chromatin association independent of H3K4 methylation. J. Biol. Chem. 285, 24548-24561 (2010).
18. N. Al Husini, P. Kudla, A. Ansari, A role for CF1A 3′ end processing complex in promoterassociated transcription. PLOS Genet. 9, e1003722 (2013).
19. A. Mayer, A. Schreieck, M. Lidschreiber, K. Leike, D. E. Martin, P. Cramer, The spt5 C-terminal region recruits yeast 3′ RNA cleavage factor I. Mol. Cell. Biol. 32, 1321-1331 (2012).
20. R. Haddad, F. Maurice, N. Viphakone, F. Voisinet-Hakil, S. Fribourg, L. Minvielle-Sébastia, An essential role for Clp1 in assembly of polyadenylation complex CF IA and Pol II transcription termination. Nucleic Acids Res. 40, 1226-1239 (2012).
21. M. Kim, S.-H. Ahn, N. J. Krogan, J. F. Greenblatt, S. Buratowski, Transitions in RNA polymerase II elongation complexes at the 3′ ends of genes. EMBO J. 23, 354-364 (2004).
22. N. Amrani, M. Minet, F. Wyers, M. E. Dufour, L. P. Aggerbeck, F. Lacroute, PCF11 encodes a third protein component of yeast cleavage and polyadenylation factor I. Mol. Cell. Biol. 17, 1102-1109 (1997).
23. M. Sadowski, B. Dichtl, W. Hübner, W. Keller, Independent functions of yeast Pcf11p in pre-mRNA 3′ end processing and in transcription termination. EMBO J. 22, 2167-2177 (2003).
24. M. A. Freire-Picos, L. J. Lombardia-Ferreira, E. Ramil, M. González-Domínguez, M. E. Cerdan, The KlCYC1 gene, a downstream region for two differentially regulated transcripts. Yeast 18, 1347-1355 (2001).
25. S. Seoane, M. Lamas-Maceiras, A. M. Rodríguez-Torres, M. A. Freire-Picos, Involvement of Pta1, Pcf11 and a KlCYC1 AU-rich element in alternative RNA 3′-end processing selection in yeast. FEBS Lett. 583, 2843-2848 (2009).
26. M. Hoque, Z. Ji, D. Zheng, W. Luo, W. Li, B. You, J. Yeon Park, G. Yehia, B. Tian, Analysis of alternative cleavage and polyadenylation by 3′ region extraction and deep sequencing. Nat. Methods 10, 133-139 (2013).
27. F. Ozsolak, P. Kapranov, S. Foissac, S. W. Kim, E. Fishilevich, A. P. Monaghan, B. John, P. M. Milos, Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell 143, 1018-1029 (2010).
28. J. H. Graber, F. I. Nazeer, P.-c. Yeh, J. N. Kuehner, S. Borikar, D. Hoskinson, C. L. Moore, DNA damage induces targeted, genome-wide variation of poly(A) sites in budding yeast. Genome Res. 23, 1690-1703 (2013).
29. L. P. Blair, J. Cao, M. R. Zou, J. Sayegh, Q. Yan, Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer. Cancers (Basel) 3, 1383 (2011).
30. S. V. Sharma, D. Y. Lee, B. Li, M. P. Quinlan, F. Takahashi, S. Maheswaran, U. McDermott, N. Azizian, L. Zou, M. A. Fischbach, K.-K. Wong, K. Brandstetter, B. Wittner, S. Ramaswamy, M. Classon, J. Settleman, A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69-80 (2010).
31. W. Lin, J. Cao, J. Liu, M. L. Beshiri, Y. Fujiwara, J. Francis, A. D. Cherniack, C. Geisen, L. P. Blair, M. R. Zou, X. Shen, D. Kawamori, Z. Liu, C. Grisanzio, H. Watanabe, Y. A. Minamishima, Q. Zhang, R. N. Kulkarni, S. Signoretti, S. J. Rodig, R. T. Bronson, S. H. Orkin, D. P. Tuck, E. V. Benevolenskaya, M. Meyerson, W. G. Kaeli, Q. Yan, Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proc. Natl. Acad. Sci. U.S.A. 108, 13379-13386 (2011).
32. B. K. Dey, L. Stalker, A. Schnerch, M. Bhatia, J. Taylor-Papidimitriou, C. Wynder, The histone demethylase KDM5b/JARID1b plays a role in cell fate decisions by blocking terminal differentiation. Mol. Cell. Biol. 28, 5312-5327 (2008).
33. L. Xie, C. Pelz, W. Wang, A. Bashar, O. Varlamova, S. Shadle, S. Impey, KDM5B regulates embryonic stem cell self-renewal and represses cryptic intragenic transcription. EMBO J. 30, 1473-1484 (2011).
34. S. U. Schmitz, M. Albert, M. Malatesta, L. Morey, J. V Johansen, M. Bak, N. Tommerup, I. Abarrategui, K. Helin, Jarid1b targets genes regulating development and is involved in neural differentiation. EMBO J. 30, 4586-4600 (2011).
35. Y. Xiang, Z. Zhu, G. Han, X. Ye, B. Xu, Z. Peng, Y. Ma, Y. Yu, H. Lin, A. P. Chen, C. D. Chen, JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 19226-19231 (2007).
36. J. Cao, Z. Liu, W. K. C. Cheung, M. Zhao, S. Y. Chen, S. W. Chan, C. J. Booth, D. X. Nguyen, Q. Yan, Histone demethylase RBP2 is critical for breast cancer progression and metastasis. Cell Rep. 6, 868-877 (2014).
37. M. R. Zou, J. Cao, Z. Liu, S. J. Huh, K. Polyak, Q. Yan, Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes. J. Biol. Chem. 289, 17620-17633 (2014).
38. Y.-C. Teng, C.-F. Lee, Y.-S. Li, Y.-R. Chen, P.-W. Hsiao, M.-Y. Chan, F.-M. Lin, H.-D. Huang, Y.-T. Chen, Y.-M. Jeng, C.-H. Hsu, Q. Yan, M.-D. Tsai, L.-J. Juan, Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res. 73, 4711-4721 (2013).
39. P. J. Lu, K. Sundquist, D. Baeckstrom, R. Poulsom, A. Hanby, S. Meier-Ewert, T. Jones, M. Mitchell, P. Pitha-Rowe, P. Freemont, J. Taylor-Papadimitriou, A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically upregulated in breast cancer. J. Biol. Chem. 274, 15633-15645 (1999).
40. S. Catchpole, B. Spencer-Dene, D. Hall, S. Santangelo, I. Rosewell, M. Guenatri, R. Beatson, A. G. Scibetta, J. M. Burchell, J. Taylor-Papadimitriou, PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. Int. J. Oncol. 38, 1267-1277 (2011).
41. S. Yamamoto, Z. Wu, H. G. Russnes, S. Takagi, G. Peluffo, C. Vaske, X. Zhao, H. K. M. Vollan, R. Maruyama, M. B. Ekram, H. Sun, J. H. Kim, K. Carver, M. Zucca, J. Feng, V. Almendro, M. Bessarabova, O. M. Rueda, Y. Nikolsky, C. Caldas, X. S. Liu, K. Polyak, JARID1B is a luminal lineage-driving oncogene in breast cancer. Cancer Cell 25, 762-777 (2014).
42. A. Roesch, M. Fukunaga-Kalabis, E. C. Schmidt, S. E. Zabierowski, P. A. Brafford, A. Vultur, D. Basu, P. Gimotty, T. Vogt, M. Herlyn, A temporarily distinct subpopulation of slowcycling melanoma cells is required for continuous tumor growth. Cell 141, 583-594 (2010).
43. A. Roesch, A. Vultur, I. Bogeski, H. Wang, K. M. Zimmermann, D. Speicher, C. Körbel, M. W. Laschke, P. A. Gimotty, S. E. Philipp, E. Krause, S. Pätzold, J. Villanueva, C. Krepler, M. Fukunaga-Kalabis, M. Hoth, B. C. Bastian, T. Vogt, M. Herlyn, Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1Bhigh cells. Cancer Cell 23, 811-825 (2013).
44. C. Mayr, D. P. Bartel, Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673-684 (2009).
45. B. H. Akman, T. Can, A. E. Erson-Bensan, Estrogen-induced upregulation and 3′-UTR shortening of CDC6. Nucleic Acids Res. 40, 10679-16088 (2012).
46. A. Lembo, F. Di Cunto, P. Provero, Shortening of 3′UTRs correlates with poor prognosis in breast and lung cancer. PLOS ONE 7, e31129 (2012).
47. Z. Xia, L. A. Donehower, T. A. Cooper, J. R. Neilson, D. A. Wheeler, E. J. Wagner, W. Li, Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types. Nat. Commun. 5, 5274 (2014).
48. J. R. Horton, X. Liu, M. Gale, L. Wu, J. R. Shanks, X. Zhang, P. J. Webber, J. S.K. Bell, S. C. Kales, B. T. Mott, G. Rai, D. J. Jansen, M. J. Henderson, D. J. Urban, M. D. Hall, A. Simeonov, D. J. Maloney, M. A. Johns, H. Fu, A. Jadhav, P. M. Vertino, Q. Yan, X. Cheng, Structural basis for KDM5A histone lysine demethylase inhibition by diverse compounds. Cell Chem. Biol. 23, 769-781 (2016).
49. C. Johansson, S. Velupillai, A. Tumber, A. Szykowska, E. S. Hookway, R. P. Nowak, C. Strain-Damerell, C. Gileadi, M. Philpott, N. Burgess-Brown, N. Wu, J. Kopec, A. Nuzzi, H. Steuber, U. Egner, V. Badock, S. Munro, N. B. LaThangue, S. Westaway, J. Brown, N. Athanasou, R. Prinjha, P. E. Brennan, U. Oppermann, Structural analysis of human KDM5B guides histone demethylase inhibitor development. Nat. Chem. Biol. 12, 539-545 (2016).
50. C. P. Masamha, Z. Xia, J. Yang, T. R. Albrecht, M. Li, A.-B. Shyu, W. Li, E. J. Wagner, CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 510, 412-416 (2014).
51. J. Cao, L. Wu, S.-M. Zhang, M. Lu, W. K. C. Cheung, W. Cai, M. Gale, Q. Xu, Q. Yan, An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting. Nucleic Acids Res. gkw660 (2016).
52. M. Gale, J. Sayegh, J. Cao, M. Norcia, P. Gareiss, D. Hoyer, J. S. Merkel, Q. Yan, Screenidentified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance. Oncotarget 7, 39931-39944 (2016).
53. G. Edwalds-Gilbert, J. Prescott, E. Falck-Pedersen, 3′ RNA processing efficiency plays a primary role in generating termination-competent RNA polymerase II elongation complexes. Mol. Cell. Biol. 13, 3472-3480 (1993).
54. K. E. Plant, M. J. Dye, C. Lafaille, N. J. Proudfoot, Strong polyadenylation and weak pausing combine to cause efficient termination of transcription in the human Gg-globin gene. Mol. Cell. Biol. 25, 3276-3285 (2005).
55. M. Yonaha, N. J. Proudfoot, Transcriptional termination and coupled polyadenylation in vitro. EMBO J. 19, 3770-3777 (2000).
56. M. Xu, M. Soloveychik, M. Ranger, M. Schertzberg, Z. Shah, R. Raisner, S. Venkatasubrahmanyan, K. Tsui, M. Gebbia, T. Hughes, H. van Bakel, C. Nislow, H. D. Madhani, M. D. Meneghini, Timing of transcriptional quiescence during gametogenesis is controlled by global histone H3K4 demethylation. Dev. Cell 23, 1059-1071 (2012).
57. M. C. Yu, F. Bachand, A. E. McBride, S. Komili, J. M. Casolari, P. A. Silver, Arginine methyltransferase affects interactions and recruitment of mRNA processing and export factors. Genes Dev. 18, 2024-2035 (2004).
58. K. E. Moore, S. M. Carlson, N. D. Camp, P. Cheung, R. G. James, K. F. Chua, A. Wolf-Yadlin, O. Gozani, A general molecular affinity strategy for global detection and proteomic analysis of lysine methylation. Mol. Cell 50, 444-456 (2013).
59. M. Bremang, A. Cuomo, A. M. Agresta, M. Stugiewicz, V. Spadotto, T. Bonaldi, Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome. Mol. Biosyst. 9, 2231-2247 (2013).
60. M. H. G. P. Raaijmakers, S. Mukherjee, S. Guo, S. Zhang, T. Kobayashi, J. A. Schoonmaker, B. L. Ebert, F. Al-Shahrour, R. P. Hasserjian, E. O. Scadden, Z. Aung, M. Matza, M. Merkenschlager, C. Lin, J. M. Rommens, D. T. Scadden, Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464, 852-857 (2010).
61. B. J. Klein, L. Piao, Y. Xi, H. Rincon-Arano, S. B. Rothbart, D. Peng, H. Wen, C. Larson, X. Zhang, X. Zheng, M. A. Cortazar, P. V. Peña, A. Mangan, D. L. Bentley, B. D. Strahl, M. Groudine, W. Li, X. Shi, T. G. Kutateladze, The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers. Cell Rep. 6, 325-335 (2014).
62. X. Liu, C. Greer, J. Secombe, KDM5 interacts with Foxo to modulate cellular levels of oxidative stress. PLOS Genet. 10, e1004676 (2014).
63. J. Sayegh, J. Cao, M. R. Zou, A. Morales, L. P. Blair, M. Norcia, D. Hoyer, A. J. Tackett, J. S. Merkel, Q. Yan, Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen. J. Biol. Chem. 288, 9408-9417 (2013).
64. L. Wang, J. Chang, D. Varghese, M. Dellinger, S. Kumar, A. M. Best, J. Ruiz, R. Bruick, S. Peña-Llopis, J. Xu, D. J. Babinski, D. E. Frantz, R. A. Brekken, A. M. Quinn, A. Simeonov, J. Easmon, E. D. Martinez, A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nat. Commun. 4, 2035 (2013).
65. L. H. Kristensen, A. L. Nielsen, C. Helgstrand, M. Lees, P. Cloos, J. S. Kastrup, K. Helin, L. Olsen, M. Gajhede, Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2, 4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor. FEBS J. 279, 1905-1914 (2012).
66. M. Vinogradova, V. S. Gehling, A. Gustafson, S. Arora, C. A Tindell, C. Wilson, K. E Williamson, G. D. Guler, P. Gangurde, W. Manieri, J. Busby, E. M. Flynn, F. Lan, H.-j. Kim, S. Odate, A. G. Cochran, Y. Liu, M. Wongchenko, Y. Yang, T. K. Cheung, T. M. Maile, T. Lau, M. Costa, G. V. Hegde, E. Jackson, R. Pitti, D. Arnott, C. Bailey, S. Bellon, R. T. Cummings, B. K. Albrecht, J.-C. Harmange, J. R. Kiefer, P. Trojer, M. Classon, An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells. Nat. Chem. Biol. 12, 531-538 (2016).
67. V. Bavetsias, R. M. Lanigan, G. F. Ruda, B. Atrash, M. G. McLaughlin, A. Tumber, N. Y. Mok, Y.-V. Le Bihan, S. Dempster, K. J. Boxall, F. Jeganathan, S. B. Hatch, P. Savitsky, S. Velupillai, T. Krojer, K. S. England, J. Sejberg, C. Thai, A. Donovan, A. Pal, G. Scozzafava, J. M. Bennett, A. Kawamura, C. Johansson, A. Szykowska, C. Gileadi, N. A. Burgess-Brown, F. von Delft, U. Oppermann, Z. Walters, J. Shipley, F. I. Raynaud, S. M. Westaway, R. K. Prinjha, O. Fedorov, R. Burke, C. J. Schofield, I. M. Westwood, C. Bountra, S. Müller, R. L.M. van Montfort, P. E. Brennan, J. Blagg, 8-substituted pyrido[3, 4-d]pyrimidin-4(3H)-one derivatives as potent, cell permeable, KDM4 (JMJD2) and KDM5 (JARID1) histone lysine demethylase inhibitors. J. Med. Chem. 59, 1388-1409 (2016).
68. J. Zhao, M. Kessler, S. Helmling, J. P. O'Connor, C. Moore, Pta1, a component of yeast CF II, is required for both cleavage and poly(A) addition of mRNA precursor. Mol. Cell. Biol. 19, 7733-7740 (1999).
69. E. Pearson, C. Moore, The evolutionarily conserved Pol II flap loop contributes to proper transcription termination on short yeast genes. Cell Rep. 9, 821-828 (2014).
70. M. A. Collart, S. Oliviero, Preparation of yeast RNA. Curr. Protoc. Mol. Biol. Chapter 13, Unit13.12 (2001).
71. B. Langmead, S. L. Salzberg, Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012).
72. A. M. Bolger, M. Lohse, B. Usadel, Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120 (2014).
73. C. Zang, D. E. Schones, C. Zeng, K. Cui, K. Zhao, W. Peng, A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 25, 1952-1958 (2009).
74. S. Heinz, C. Benner, N. Spann, E. Bertolino, Y. C. Lin, P. Laslo, J. X. Cheng, C. Murre, H. Singh, C. K. Glass, Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576 (2010).
75. J. T. Robinson, H. Thorvaldsdóttir, W. Winckler, M. Guttman, E. S Lander, G. Getz, J. P. Mesirov, Integrative genomics viewer. Nat. Biotechnol. 29, 24-26 (2011).
76. L. A. Selth, C. Gilbert, J. Q. Svejstrup, RNA immunoprecipitation to determine RNA-protein associations in vivo. Cold Spring Harb. Protoc. pdb.prot5234 (2009).